Alzai Health Corp. (TSXV:ALZI)

Market Cap	28.87M
Revenue (ttm)	n/a
Net Income	-1.50M
EPS	-0.05
Shares Out	64.15M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,004
Open	0.4500
Previous Close	0.4700
Day's Range	0.4500 - 0.4500
52-Week Range	0.4200 - 0.5000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Alzai Health

Alzai Health Corp., a healthcare technology company, provides artificial intelligence driven solution for risk screening. The company offers risk screening solutions for Mild Cognitive Impairment, Alzheimer’s Disease, and Related Dementias. The company’s Alzai Risk Screening Solution offers prevention strategies, timely intervention and diagnosis of diseases. It caters to various markets including healthcare providers and payors, pharmaceutical companies, research organizations, and research sites, clinical trials and research companies, and pu...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2024
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: ALZI

Financial Performance

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 6, 2026

Data Sources Report a data error